← Back to Clinical Trials
Recruiting NCT07306533

Effect of Menstrual Phase on the Anesthetic Efficacy

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Pulpitis - Irreversible
Sponsor Jamia Millia Islamia
Study Type INTERVENTIONAL
Phase N/A
Enrollment 150
Sex FEMALE
Min Age 18 Years
Max Age 45 Years
Start Date 2025-09-11
Completion 2026-03-10
Interventions
Inferior Alveolar Nerve Block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this observational prospective clinical study is to learn whether the menstrual phase influences the anesthetic efficacy of inferior alveolar nerve block (IANB) in female patients aged 20-40 years with symptomatic irreversible pulpitis in mandibular molars. The main questions it aims to answer are: Does the success rate of IANB vary across different phases of the menstrual cycle? Are certain menstrual phases associated with a higher likelihood of anesthetic failure during endodontic access preparation? Researchers will compare five menstrual phase groups (menstrual, follicular, ovulatory, luteal, and premenstrual) to see if hormonal fluctuations affect anesthetic success. Participants will: Receive a standardized inferior alveolar nerve block using 2% lidocaine with 1:80,000 epinephrine Undergo cold testing and access cavity preparation to assess anesthetic success Have intraoperative pain recorded using the Heft-Parker Visual Analog Scale (HPVAS), with menstrual phase information recorded confidentially and blinded to the treating clinician

Eligibility Criteria

Inclusion Criteria * Female patients aged 20-40 years. * Regular menstrual cycles (28 ± 3 days). * Diagnosed with symptomatic irreversible pulpitis in mandibular molars. * Indicated for root canal therapy. * Willing to provide informed consent. Exclusion Criteria * Use of oral contraceptives or hormonal therapy. * Irregular menstrual cycles. * Pregnancy or lactation. * Systemic disease affecting pain perception (e.g., diabetes, neuropathies). * Recent use of analgesics or sedatives (within 24 hours). * Allergy to local anesthetics.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}